VeriMomdi-c12-15 pareth-4 phosphate é seguro durante a gravidez?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
Pregnancy-safe products containing di-c12-15 pareth-4 phosphate
Related ingredients
Frequently asked questions
- di-c12-15 pareth-4 phosphate é seguro durante a gravidez?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
- di-c12-15 pareth-4 phosphate é seguro durante a amamentação?
- Same rationale as pregnancy: no authoritative reproductive/breast‑milk transfer hazards identified. Low but measurable systemic exposure from topical use is possible but no data demonstrating transfer in milk. Sources: ECHA Annex VI, PubChem, CosIng; no SCCS/CIR hazard finding.
- di-c12-15 pareth-4 phosphate é seguro para a pele do bebê?
- No infant-specific reproductive or developmental toxicity data found. Because infant skin has a higher surface‑area‑to‑weight ratio and an immature barrier, topical exposure was up‑rated by +1 relative to adult exposure (adult e=1 → infant e=2). No evidence indicates increased mechanistic hazard for infants. Sources: CosIng/PubChem for ingredient use and identity; no SCCS/CIR concerns or ECHA harmonised classification.
- Como o VeriMom pontua di-c12-15 pareth-4 phosphate?
- O VeriMom pontua di-c12-15 pareth-4 phosphate em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a di-c12-15 pareth-4 phosphate na gravidez?
- Veja nossa lista curada de alternativas seguras a di-c12-15 pareth-4 phosphate com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.